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Background: The aim of this review was to systematically review and meta-analyze the effects of yoga on
symptoms of schizophrenia, quality of life, function, and hospitalization in patients with schizophrenia.
Methods: MEDLINE/Pubmed, Scopus, the Cochrane Library, PsycInfo, and IndMED were screened through August
2012. Randomized controlled trials (RCTs) comparing yoga to usual care or non-pharmacological interventions were
analyzed when they assessed symptoms or quality of life in patients with schizophrenia. Cognitive function, social
function, hospitalization, and safety were defined as secondary outcomes. Risk of bias was assessed using the risk of
bias tool recommended by the Cochrane Back Review Group. Standardized mean differences (SMD) and 95%
confidence intervals (CI) were calculated.
Results: Five RCTs with a total of 337 patients were included; 2 RCTs had low risk of bias. Two RCTs compared
yoga to usual care; 1 RCT compared yoga to exercise; and 2 3-arm RCTs compared yoga to usual care and exercise.
No evidence was found for short-term effects of yoga compared to usual care on positive symptoms (SMD = −0.58;
95% CI −1.52 to 0.37; P = 0.23), or negative symptoms (SMD = −0.59; 95% CI −1.87 to 0.69; P = 0.36). Moderate
evidence was found for short-term effects on quality of life compared to usual care (SMD = 2.28; 95% CI 0.42 to
4.14; P = 0.02). These effects were only present in studies with high risk of bias. No evidence was found for
short-term effects on social function (SMD = 1.20; 95% CI −0.78 to 3.18; P = 0.23). Comparing yoga to exercise, no
evidence was found for short-term effects on positive symptoms (SMD = −0.35; 95% CI −0.75 to 0.05; P = 0.09),
negative symptoms (SMD = −0.28; 95% CI −1.42 to 0.86; P = 0.63), quality of life (SMD = 0.17; 95% CI −0.27 to 0.61;
P = 0.45), or social function (SMD = 0.20; 95% CI −0.27 to 0.67; P = 0.41). Only 1 RCT reported adverse events.
Conclusions: This systematic review found only moderate evidence for short-term effects of yoga on quality of life.
As these effects were not clearly distinguishable from bias and safety of the intervention was unclear, no
recommendation can be made regarding yoga as a routine intervention for schizophrenia patients.
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Schizophrenia is a severe mental disorder that manifests
itself mainly by positive symptoms (delusions and hallu-
cinations) and negative symptoms (lack of motivation,
reduction in spontaneous speech, and social withdrawal)
[1,2]. Impaired cognitive function (difficulties in mem-
ory, attention, and executive functioning) is a third im-
portant symptom cluster [1,2] that is mainly associated
with negative symptoms [3]. This psychopathology has
substantial impact on quality of life, well-being and* Correspondence: h.cramer@kliniken-essen-mitte.de
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reproduction in any medium, provided the orsocial and occupational function [4-6] and thus creates a
considerable socioecomic burden [7,8].
While psychopharmaceutics are effective in improving
positive symptoms, their effectiveness on negative symp-
toms is limited [2,9]. About 30% of patients are therapy-
refractory [10]. It has recently been demonstrated that
physical activity can relieve symptoms and improve
function and quality of life in patients with schizophre-
nia [11,12]. Yoga is a traditional Indian practice that
combines physical activity with lifestyle advice and body
awareness techniques such as breath control and medi-
tation [13,14]. Yoga is thought to relieve stress and men-
tal symptoms by increased balance of body, thoughts,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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yoga can improve mental functioning and quality of life
in physical conditions such as cancer [16,17], menopause
[18], and pain [19,20]. As well, yoga has been shown to
improve mental disorders such as depression [21], and
anxiety disorders [22]. While a prior systematic review
suggests effectiveness of yoga in relieving symptoms and
improving well-being in patients with schizophrenia
[23], no meta-analysis is available.
Therefore, the aim of this review was to systematically
assess and meta-analyze the effectiveness of yoga in
patients with schizophrenia.Methods
PRISMA guidelines for systematic reviews and meta-
analyses [24] and the recommendations of the Cochrane
Collaboration [25] were followed.Eligibility criteria
Types of studies
Randomized controlled trials (RCTs) and randomized
cross-over studies (only data from the first active treat-
ment phase were used) were eligible. No language
restrictions were applied. Studies were eligible only if
they were published as full paper.Types of participants
Adults with schizophrenia were eligible if they were
diagnosed by
1. The Diagnostic and Statistical Manual (DSM) [1], the
Research Diagnostic Criteria (RDC) [26], or the
International Classification of Disease (ICD) [27];
2. Any other clinician-based diagnosis criterion.
3. Unclear diagnostic criteria but were currently treated
for schizophrenia.
Studies involving participants with comorbid physical
or mental disorders were eligible for inclusion.Types of interventions
Experimental Yoga interventions including at least 1 of
the following: physical activity, breath control, meditation,
and/or lifestyle advice (based on yoga theory and/or
traditional yoga practices) were eligible. No restrictions
were made regarding yoga tradition, length, frequency or
duration of the program. Studies on multimodal interven-
tions, such as mindfulness-based stress reduction and
mindfulness-based cognitive therapy (that include yoga
amongst others) [28] were excluded. Co-interventions
were allowed.Control
1. Usual care or standard care.
2. Exercise or other active non-pharmacological
interventions.
Types of outcome measures
To be eligible, RCTs had to assess at least 1 primary
outcome:
1. Improvement in the severity of symptoms of
schizophrenia, measured by clinician-rated scales,
such as the Brief Psychiatric Rating Scale (BPRS)
[29], the Positive and Negative Syndrome Scale
(PANSS) [30], the Clinical Global Impression Scale
(CGI) [31], or any other validated scale.
2. Improvement in quality of life or well-being
measured by any validated scale such as the WHO
Quality of Life-BREF quality of life assessment [32].
Secondary outcomes included:
1. Improvement in cognitive function, measured by test
batteries such as the NIMH Measurement and
Treatment Research to Improve Cognition in
Schizophrenia (MATRICS) [33] or any other
validated battery.
2. Social function, measured by any validated scale such
as the Socio-Occupational Functioning Scale (SOFS)
[34].
3. Hospitalization, assessed as e.g. number of
admissions or days in hospital in a pre-defined
follow-up period [35].
4. Safety of the intervention assessed as amount of
extrapyramidal symptoms or number of adverse
events.
Search methods
Medline/PubMed, Scopus, the Cochrane Library, PsycINFO,
and IndMED were searched from their inception through
28 August 2012. The literature search was constructed
around search terms for “yoga” and search terms for
“schizophrenia”. For PubMed, the following search strategy
was used: (“Yoga”[Mesh] OR “Yoga”[Title/Abstract] OR
“Yogic”[Title/Abstract]) AND (“Schizophrenia”[Mesh] OR
“Schizophrenia”[Title/Abstract] OR “Schizophrenic”[Title/
Abstract]). The search strategy was adapted for each data-
base as necessary.
Additionally, reference lists of identified original arti-
cles or reviews were searched manually.
Abstracts identified during literature search were
screened by 2 review authors independently. Potentially
eligible articles were read in full by 2 review authors to
determine whether they met the eligibility criteria.
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until consensus was reached. If necessary, additional in-
formation was obtained from the study authors.Data extraction and management
Two authors independently extracted data on patients
(e.g. age, diagnosis), methods (e.g. randomization, allocation
concealment), interventions (e.g. yoga type, frequency, and
duration), control interventions (e.g. type, frequency, dur-
ation), co-interventions, outcomes (e.g. outcome measures,
assessment time points), and results using an a priori devel-
oped data extraction form. Discrepancies were discussed
with a third review author until consensus was reached. If
necessary, the study authors were contacted for additional
information.
Risk of bias in individual studies
Two authors independently assessed risk of bias using
the risk of bias tool proposed by the Cochrane Back
Review Group [36]. This tool assesses risk of bias on the
following domains: selection bias, performance bias, at-
trition bias, reporting bias, and detection bias using 12
criteria. Risk of bias was assessed for each criterion as
1) low risk of bias, 2) unclear, 3) high risk of bias. Discrep-
ancies were discussed with a third review author until
consensus is reached. Studies that met at least 6 of the 12
criteria and had no serious flaw were rated as having low
risk of bias. Studies that met fewer than 6 criteria or had a
serious flaw were rated as having high risk of bias [36].
Data analysis
Assessment of effect size
Separate meta-analyses were conducted for
1) Short-term and long-term effects. Short-term
outcomes were defined as outcome measures taken
closest to 12 weeks after randomization and long-
term outcomes as measures taken closest to
12 months after randomization [35].
2) Different control interventions (usual care; exercise).
Meta-analyses were conducted using Review Manager
5 software (Version 5.1, The Nordic Cochrane Centre,
Copenhagen) by a random effects model [25]. Meta-
analyses were conducted if at least 2 RCTs for a specific
comparison were available [25].
Standardized mean differences (SMD) with 95% confi-
dence intervals (CI) were calculated as the difference in
means between groups divided by the pooled standard
deviation. Where no standard deviations were available,
they were calculated from standard errors, confidence
intervals or t values [25], or attempts were made to ob-
tain the missing data from the trial authors by email.Where data were suspected to be skewed, this was
tested by subtracting the observed mean from the
highest possible value of the respective outcome meas-
ure and dividing this by the standard deviation [25].
Ratios below 2 were regarded as indicating possible
skewness [25].
A negative SMD was defined to indicate beneficial
effects of yoga compared to the control intervention for
symptoms and hospitalization while a positive SMD was
defined to indicate beneficial effects of yoga compared
to the control intervention for well-being and function.
If necessary, scores were inverted by subtracting the
mean from zero [25].
Cohen’s categories were used to evaluate the magni-
tude of the overall effect size with 1) SMD = 0.2 to 0.5:
small; 2) SMD = 0.5 to 0.8: moderate and 3) SMD > 0.8:
large effect sizes [37].
Levels of evidence were determined as 1) strong evi-
dence: consistent findings among multiple RCTs with
low risk of bias; 2) moderate evidence: consistent find-
ings among multiple high-risk RCTs and/or one low-risk
RCT; 3) limited evidence: one RCT with high risk of
bias; 4) conflicting evidence: inconsistent findings among
multiple RCTs; and 5) no evidence: no RCTs [38].Assessment of heterogeneity
The I2 statistics, a measure of how much variance be-
tween studies can be attributed to differences between
studies rather than chance, was used to analyze statis-
tical heterogeneity between studies. The magnitude of
heterogeneity was categorized as 1) I2 = 0-25%: low
heterogeneity; I2 = 26-50%: moderate heterogeneity; I2 =
51-75%: substantial heterogeneity; and I2 = 76-100%:
considerable heterogeneity [25,39]. The Chi2 test was
used to assess whether differences in results were com-
patible with chance alone. Given the low power of this
test when only few studies or studies with low sample
size are included in a meta-analysis, a P-value ≤ 0.10 was
regarded to indicate significant heterogeneity [25].Subgroup and sensitivity analyses
Subgroup analyses were conducted for type of partici-
pants (manual-based diagnosis; other or unclear diagno-
sis). Further subgroup analyses were conducted for
duration of the intervention (less than 12 weeks; more
than 12 weeks).
To test the robustness of significant results, sensitivity
analyses were conducted for studies with high versus
low risk of bias.
If statistical heterogeneity was present in the respective
meta-analysis, subgroup and sensitivity analyses were
also used to explore possible reasons for heterogeneity.
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If at least 10 studies were included in a meta-analysis,
the study protocol planned to assess publication bias by
visual analysis of funnel plots generated using Review
Manager 5 software [40]. As less than 10 studies were fi-




The literature search retrieved 109 records, and 1 add-
itional record was retrieved through other sources.
Fifty-three nonduplicate records were screened and 47
records were excluded because they were no RCTs
and/or yoga was not an intervention. Six full-text arti-
cles reporting on 5 RCTs with a total of 337 patients
were included in qualitative analysis [41-46]. One ran-
domized cross-over trial was excluded from quantita-
tive synthesis as data from the first active treatment
phase were not reported and could not be retrieved
from the trial authors [44]. Finally, 4 studies with 288
patients were included in the meta-analysis (Figure 1).
Study characteristics
Characteristics of the sample, interventions, outcome as-
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Figure 1 Flowchart of the results of the literature search.Setting and participant characteristics
Of the 5 RCTs that were included, 3 originated from
Asia (2 from India [41-43], and 1 from China [46]), 1
from North America (USA) [45], and 1 from Europe
(Belgium) [44]. Patients were recruited from psychiatric
outpatient services [41-43], and/or psychiatric inpatient
services [42-45].
Patients in 2 RCTs were diagnosed with schizophrenia
according to DSM-IV [41-43], and patients in 1 RCTs
were diagnosed according to CCD-3 (Chinese Classification
of Mental Disorders) [46]. The remaining 2 RCTs included
patients that were hospitalized for schizophrenia [44,45]
or schizoaffective disorder [44] but did not state the diag-
nostic criteria used. Patients in 3 RCTs were required to
have a clinical global severity scale rating of at least 3
[41,42] or 4 [43,44]. Mean duration of illness ranged
from 76.4 months to 129.7 months with a median of
88.6 months. Patients in all RCTs were on stabilized anti-
psychotic medication. Patients’ mean age ranged from
28.2 years to 48.1 years with a median age of 32.5 years.
Between 31.0% and 60.0% (median: 33.3%) of patients in
each study were female.
Intervention characteristics
Yoga was based on the yoga module developed by
Swami Vivekananda Yoga Anusandhana Samsthana
(SVYASA) in 2 RCTs [41-43], and on the principles of47 records excluded
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Table 1 Characteristics of the included studies





(N, Diagnosis, Age) (program length, frequency, duration)











et al., 2012 [42]
119 patients
with Schizophrenia


























2. Usual care (UC)
4 months





























et al., 2007 [43]
61 patients with
Schizophrenia









































b) YOGA > EX
c) YOGA > EX.
2)
a) YOGA > EX
b) YOGA > EX
c) YOGA > EX
d) YOGA > EX
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not state yoga tradition [45,46]. All yoga programs
included yoga postures, breath control, and meditation/
relaxation. Program length and intensity varied and
included: 1 single 30-minute session [44]; 2 45-minute
sessions per week over a period of 8 weeks [44]; 4–5
60-minute sessions per week over a period of 8 weeks
[46]; and 25 45-minute sessions over a period of
1 months followed by 3 months of home-based yoga
[41-43]. Yoga was taught by physicians [45], physical or
occupational therapists trained to teach yoga therapy
[43,44,46], or certified yoga teachers [41,42].
Two RCT compared yoga to usual care [45,46], and 1
RCT compared yoga to exercise [43]. Two 3-arm RCTs
compared yoga to usual care and exercise [41,42,44].
Exercise interventions were matched to the yoga inter-
ventions in terms of frequency, length, and duration and
included walking, jogging, exercise in standing and sit-
ting postures, and relaxation in 2 RCTs [41-43]. In 1
RCT a single 30-minute yoga session was compared to a
single 20-minute ergometer training session [44]. Exer-
cise was taught by (physical) therapists trained to teach
exercise therapy [41-44].
Outcome measures
Symptoms of schizophrenia were assessed in 3 RCTs
using the Positive and Negative Syndrome Scale [41-
43,45]. Quality of life or well-being was assessed in 4 stud-
ies using the WHO Quality of Life-BREF quality of life as-
sessment [43,45], the General Quality of Life Inventory-74
[46], or the Subjective Exercise Experiences Scale [44].
Cognitive function was measured by 1 RCT using the
Tool for Recognition of Emotions in Neuropsychiatric
Disorders [41]. Social function was assessed in 4 RCTs
using the Socio-Occupational Functioning Scale [41-43],
the WHO Quality of Life-BREF quality of life assessment
[45], or the General Quality of Life Inventory-74 [46]. No
study reported data on hospitalization. Safety was assessed
as number of adverse events in 1 RCT [45] and as amount
of extrapyramidal symptoms in 2 RCTs [41-43].
While all RCTs reported short-term effects, no RCT
reported long-term effects.
Risk of bias in individual studies
Two RCTs had low risk of bias [41-43], and 3 RCTs had
high risk of bias [44-46] (Table 2). Risk of selection bias was
mixed; all RCTs reported adequate randomization, while
only 1 RCT reported adequate allocation concealment
[41,42]. No RCT reported blinding of participants or provi-
ders, but 3 RCTs reported adequate blinding of outcome
assessors [41-43,45]. Co-interventions were adequately
reported and comparable between groups in 3 RCTs [41-
43,46]. Attrition bias was high in all studies as no RCT had
an acceptable and described drop-out rate and no RCT
used an intention-to-treat analysis. Risk of selectiveoutcome reporting was high in 1 study that reported differ-
ent outcomes from the same RCT in multiple publications
without disclosing the entire study protocol [41,42].Outcomes
One RCT did not report means and SDs due to the
skewness of the baseline data [42]. Post-intervention
means and SDs were provided by the trial authors on re-
quest. These data were tested for skewness and there
was no evidence for skewness.Yoga vs. usual care
Meta-analyses revealed no evidence for short-term
effects of yoga on positive symptoms (SMD = −0.58; 95%
CI −1.52 to 0.37; P = 0.23; heterogeneity: I2 = 66%; Chi2 =
2.98; P = 0.08) or negative symptoms (SMD= −0.59; 95%
CI −1.87 to 0.69; P = 0.36; heterogeneity: I2 = 80%; Chi2 =
5.04; P = 0.02) compared to usual care (Figure 2). There
was moderate evidence for a large short-term improve-
ment of quality of life in the yoga groups compared to
usual care (SMD= 2.28; 95% CI 0.42 to 4.14; P = 0.02; het-
erogeneity: I2 = 89%; Chi2 = 9.01; P < 0.01) (Figure 2). Only
1 RCT assessed cognitive function [41] and there was no
evidence for group differences in this RCT (SMD= 0.08;
95% CI −0.49 to 0.64). No evidence was found for short-
term effects on social function (SMD= 1.20; 95% CI −0.78
to 3.18; P = 0.23; heterogeneity: I2 = 96%; Chi2 = 54.40;
P < 0.01) (Figure 3).Yoga vs. exercise
When comparing yoga to exercise, no evidence was found
for short-term effects on positive symptoms (SMD= −0.35;
95% CI −0.75 to 0.05; P = 0.09; heterogeneity: I2 = 0%; Chi2 =
0.04; P = 0.85), or negative symptoms (SMD= −0.28; 95%
CI −1.42 to 0.86; P = 0.63; heterogeneity: I2 = 87%; Chi2 =
7.49; P < 0.01) (Figure 2). One RCT assessed quality of life
[43] and there was no evidence for group differences in this
RCT (SMD= 0.17; 95% CI −0.27 to 0.61). Similarly, only 1
RCT assessed cognitive function [41] and there was no evi-
dence for group differences (SMD= 0.14; 95% CI −0.47 to
0.74). No evidence was found for short-term effects on so-
cial function (SMD= 0.20; 95% CI −0.27 to 0.67; P = 0.41;
heterogeneity: I2 = 27%; Chi2 = 1.36; P = 0.24) (Figure 3).Safety
Safety data were reported in 3 RCTs. One RCT reported
adverse events and reported that no serious adverse
events were observed [45]. Two RCT assessed extrapyr-
amidal symptoms and found no differences between
yoga and usual care [41,42] or exercise [41-43].
Table 2 Risk of bias of the included studies
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Figure 2 Effects of yoga compared to usual care and exercise on primary outcomes: positive symptoms, negative symptoms, and
quality of life.
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Favours control Favours yoga
Figure 3 Effects of yoga compared to usual care and exercise on secondary outcomes: social function.
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One study with unclear method of diagnosis [45] found
limited evidence for effects on positive and negative
symptoms when comparing yoga to usual care. These
group differences were absent in studies with manual-
based diagnosis [41,42].
One study that used a short (less than 3 weeks) yoga
intervention [45] found limited evidence for effects on
positive and negative symptoms when comparing yoga
to usual care. These group differences were absent in
studies that used long (more than 3 weeks) yoga inter-
ventions [41,42].
Sensitivity analyses
Sensitivity analyses demonstrated a significant effect
on quality of life in studies with high risk of bias
comparing yoga to usual care [45,46] whereas no
studies with low risk of bias where available for this
comparison.
Risk of bias across studies
As less than 10 studies were included in each meta-ana-
lysis, funnel plots were not analyzed.
Discussion
This systematic review found moderate evidence for
short-term improvements of quality of life in schizo-
phrenia patients after yoga interventions. Only limited
evidence was found for symptom relief and this evidence
was based on only 1 study with unclear diagnostic
method and short yoga intervention. No evidence was
found for improved function. Safety data were only in-
sufficiently reported.The results of this review are not in line with those of
previous qualitative reviews on yoga for schizophrenia.
Vancampfort et al. [23] included 3 RCTs that were also
included in the present meta-analysis and concluded
that yoga can be a useful add-on treatment to reduce
psychopathology in schizophrenia. As these conclusions
were based on the results that were reported in the ori-
ginal articles, and only 2 out of 3 RCTs reported post-
intervention group comparisons, these results were not
robust against reporting bias. Another review that
included 4 RCTs that were also included in the present
review concluded that the prescription of yoga for
schizophrenia was evidence-based [47]. A third review
that included also unpublished and uncontrolled studies
concluded that yoga has been demonstrated to be feas-
ible and effective as an add-on treatment in schizophre-
nia [48]. None of these reviews included a meta-analysis.
The limited evidence that shorter yoga interventions
might be more effective than longer ones is in line with
the results of meta-analyses on yoga for pain [19] or fa-
tigue [49].
External and internal validity
Patients in the included studies were recruited from psy-
chiatric inpatient and outpatient services in North
America, Europe, and Asia. Patients diagnosed by differ-
ent manuals were included. All patients were treated
with antipsychotic medication. The majority of patients
were males and in the reproductive age range and were
diagnosed on average 6 to 11 years ago. The results of
this review are therefore applicable to the vast majority
of schizophrenia patients in clinical practice. They might
however be less applicable to newly diagnosed schizo-
phrenia patients.
Cramer et al. BMC Psychiatry 2013, 13:32 Page 11 of 12
http://www.biomedcentral.com/1471-244X/13/32Three out of 5 studies had high risk of bias [44-46],
one of them was not included in the meta-analysis. Only
1 study reported adequate allocation concealment [41,42];
and only 3 studies reported adequate blinding of outcome
assessors [41-43,45]. No study had acceptable drop-out
rates or applied an intention-to-treat analysis. The only
evidence of effectiveness that was revealed in meta-
analysis – the effect on quality of life when comparing
yoga to usual care – was present only in studies with high
risk of bias. Therefore, this effect cannot be regarded as
robust against potential methodological biases.
Strengths and weaknesses
This is the first meta-analysis available on yoga for schizo-
phrenia. Besides psychopathology, patient-centered out-
comes were used [35]. No language restrictions were
imposed; thereby this work could include more RCTs than
prior reviews [23,48].
The primary limitation of this review is the small total
number of eligible RCTs. Therefore, the effect size esti-
mates derived in the meta-analyses were highly unstable.
The overall high risk of bias further restricts the inter-
pretation of the results and publication bias could not be
ruled out. As no RCT reported longer-term effects, the
results of this review are only applicable to short-term
effects. Furthermore, means and SDs were not included
in the original publication of 1 RCT [42]. While data
were published for a subsample of this RCT [41], we
decided to use data that were provided by the trial
authors on request. While this approach improved the
power of the analysis, it might also have introduced bias.
Co-interventions were not clearly described in all RCTs;
safety data were insufficiently reported; and no RCT
reported adherence rates. While the yoga intervention it-
self was comparable in all RCTs, the intensity of the pro-
gram varied.
Implications for further research
Given the low number of available studies, definite
conclusions about the effectiveness of yoga in patients
with schizophrenia cannot be drawn at the moment.
Future studies should ensure rigorous methodology
and reporting, mainly adequate sample size, adequate
randomization, allocation concealment, intention-to
treat analysis, and blinding of at least outcome asses-
sors [50]. Yoga often involves physical exercise and/or
meditation or mindfulness practice [13,14]. As exercise
interventions have shown effectiveness in improving
schizophrenia psychopathology [11], and mindfulness-
based interventions have shown preliminary but promis-
ing effects in patients with psychosis [51,52], dismantling
studies that separately evaluate the effects of different
components of yoga seem warranted. As yoga has been
shown to promote body awareness [15] which seems to beimpaired in schizophrenia patients [53], it might be worth-
while to investigate the effects of yoga on body awareness
in schizophrenia.
Conclusions
This systematic review found only moderate evidence for
short-term effects of yoga on quality of life. As these effects
were not clearly distinguishable from bias and safety of the
intervention remains unclear in this patient population, no
recommendation can be made regarding yoga as a routine
intervention for schizophrenia patients.
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